Developed by Merz Pharmaceuticals, Memary is an N-methyl-D-aspartate (NMDA) receptor antagonist which has been approved by European EMEA in 2002 and by the US Food and Drug Administration
Fampyra 10mg tablets are prolonged-release (sustained release) tablet formulation of the drug fampridine (4-aminopyridine or 4-AP). Biogen Idec Neurology Research & Development head Alfred Sandrock said tens of
The two mixers are mounted on a common base and are connected with piping to facilitate continuous circulation of materials until the desired dispersion is obtained. A built
Eisai said the drug has got the positive opinion as a monotherapy indicated in the treatment of patients with locally advanced or metastatic breast cancer who have received
The approval is based on Prazaxa RE-LY trial, which demonstrated reduction in risk of stroke and systemic embolism by 35% beyond the reduction achieved with well controlled warfarin
With this milestone, Boehringer Ingelheim and MorphoSys have reached eighth clinical milestone during the year 2010. MorphoSys’ clinical pipeline now comprises 10 partnered programs in Phase 1 and
The tablets will be available in 10mg, 20mg and 40mg. The most frequent adverse events reported by patients participating in clinical trials of Viibryd included diarrhoea, nausea, vomiting,
The HMS electronic health record (EHR) is 2011/2012 compliant in accordance with the criteria adopted by the Secretary of Health and Human Services. The certification enables providers to
Novartis said Gilenya prevents the white blood cells from reaching the CNS, where they could potentially attack the protective covering around the nerve fibers, resulting in less inflammatory
The new software drivers allow the Hamilton MICROLAB VENUS software to control the KiNEDx arm by calling functions or through preprogrammed moves, and the user can easily make
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.